alpiropride

Suppliers

Names

[ CAS No. ]:
81982-32-3

[ Name ]:
alpiropride

[Synonym ]:
RIV 2093
5-(Methylaminosulfonyl)-N-[(1-allyl-2-pyrrolidinyl)methyl]-2-methoxy-4-aminobenzamide

Chemical & Physical Properties

[ Density]:
1.227g/cm3

[ Molecular Formula ]:
C17H26N4O4S

[ Molecular Weight ]:
382.47800

[ Exact Mass ]:
382.16700

[ PSA ]:
122.14000

[ LogP ]:
2.94740

[ Index of Refraction ]:
1.56

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CV2311580
CHEMICAL NAME :
Benzamide, 4-amino-2-methoxy-5-((methylamino)sulfonyl)-N-((1-(2- propenyl)-2-pyrrolidi nyl) methyl)-
CAS REGISTRY NUMBER :
81982-32-3
LAST UPDATED :
199009
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C17-H26-N4-O4-S
MOLECULAR WEIGHT :
382.53

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
184 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
204 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
44 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550179